Cargando…

Optimizing arginine deprivation for hard-to-treat cancers

Detalles Bibliográficos
Autores principales:	Khadeir, Ramsay, Szyszko, Teresa, Szlosarek, Peter W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722492/ https://www.ncbi.nlm.nih.gov/pubmed/29228540 http://dx.doi.org/10.18632/oncotarget.22099

Ejemplares similares

Bench-to-Bedside Studies of Arginine Deprivation in Cancer
por: Field, George C., et al.
Publicado: (2023)

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
por: Beddowes, Emma, et al.
Publicado: (2017)

Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
por: Carpentier, Joséphine, et al.
Publicado: (2022)

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
por: Phillips, Melissa M., et al.
Publicado: (2013)

Role of 3'-Deoxy-3'-[(18)F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
por: Szyszko, Teresa A., et al.
Publicado: (2022)

Arginine deprivation therapy for malignant melanoma
por: Yoon, Jung-Ki, et al.
Publicado: (2012)

Deprivation of arginine by recombinant human arginase in prostate cancer cells
por: Hsueh, Eddy C, et al.
Publicado: (2012)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

Taming Peptides with Peptides: Neutralizing Proline-Glycine-Proline with l-Arginine-Threonine-Arginine to Treat Cigarette Smoke–induced Emphysema
por: Madison, Matthew C., et al.
Publicado: (2019)

Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers
por: Cohen, Victoria M. L., et al.
Publicado: (2018)

Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review
por: Al-Koussa, Houssam, et al.
Publicado: (2020)

Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers
por: Rogers, Leonard C., et al.
Publicado: (2019)

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors
por: Hajji, Nabil, et al.
Publicado: (2022)

An Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage Invasion
por: Goldman-Pinkovich, Adele, et al.
Publicado: (2016)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
por: Li, Ying-Ying, et al.
Publicado: (2016)

Cancer Screening in Hard-to-Reach Populations
por: Terry, Paul D.
Publicado: (2017)

HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells
por: Nurcahyanti, Agustina DR, et al.
Publicado: (2016)

Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment
por: Chu, Yu-De, et al.
Publicado: (2023)

Hard to Please
Publicado: (1877)

Arginine deprivation in KB cells: I. Effect on cell cycle progress
por: Weissfeld, AS, et al.
Publicado: (1977)

l-Arginine deprivation impairs Leishmania major-specific T-cell responses
por: Munder, Markus, et al.
Publicado: (2009)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
por: Alexandrou, Constantinos, et al.
Publicado: (2018)

The true effect of lithium is hard to determine
por: Nielsen, René Ernst, et al.
Publicado: (2023)

Dangers of the 'Hard' Line
Publicado: (1966)

The Way of the Transgressor Is Hard
Publicado: (1897)

Continued initiation of DNA synthesis in arginine-deprived Chinese hamster ovary cells
Publicado: (1977)

Arginine deprivation in KB cells. II. Characterization of the DNA synthesized during starvation
Publicado: (1977)

Differential impact of l-arginine deprivation on the activation and effector functions of T cells and macrophages
por: Choi, B.-S., et al.
Publicado: (2009)

P042: Metabolic regulation of adaptive response to arginine deprivation in Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2022)

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
por: Burrows, Natalie, et al.
Publicado: (2016)

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
por: Przystal, Justyna Magdalena, et al.
Publicado: (2018)

Gas6/Axl in arginine-starvation therapy
por: Tsai, Wen-Bin, et al.
Publicado: (2015)

Female platelets are hard to control
por: Appelman, Y., et al.
Publicado: (2011)

Nutrition is a hard science
por: Kohlmeier, Martin
Publicado: (2018)

Decision of the “Hard Rubber” Contest
Publicado: (1859)

Cannot write session to /tmp/vufind_sessions/sess_oi2obndihu5fmv4skb7r5aecd2